BlueOcean Ventures
Status
ACTIVE
Global HQ
Geneva, Switzerland
Countries of investment
- America
- Asia
- and Africa
Investment stages
- Seed
Industries
- Health Tech
- Biotechnology
About
BlueOcean Ventures is an investment company that specializes in early stage medical device and life science companies. Founded by Faris Sabeti, Emmanuel de Watteville, Sacha Haymoz, and Thomas Zehnder, the firm prides itself on a team with extensive experience in building, managing, and mentoring startups. They leverage a vast network of industry contacts and experts to support their portfolio companies. Notably, Emmanuel de Watteville launched BlueOcean Ventures ICO in Q4 2017 to pursue his passion for blockchain and tokenization. The company is based in Geneva, Switzerland, with several key industry partners.
BlueOcean Ventures is an investment company that specializes in early stage medical device and life science companies. Founded by Faris Sabeti, Emmanuel de Watteville, Sacha Haymoz, and Thomas Zehnder, the firm prides itself on a team with extensive experience in building, managing, and mentoring startups. They leverage a vast network of industry contacts and experts to support their portfolio companies. Notably, Emmanuel de Watteville launched BlueOcean Ventures ICO in Q4 2017 to pursue his passion for blockchain and tokenization. The company is based in Geneva, Switzerland, with several key industry partners.
Investment Thesis
BlueOcean Ventures invests in early stage medical device and life science companies. Unlike other funds, the four Founders of BlueOcean Ventures have a longstanding track record in building, managing, and coaching startup companies. BlueOcean Ventures supports their portfolio companies with a large network of experts and industry contacts.
Manager's Experience
Backed by extensive experience in venture capital, the fund manager has successfully led over 50 investments in technology and healthcare sectors across North America and Europe. Their operator-first approach emphasizes strategic partnerships and operational support, resulting in notable exits that include several high-growth startups. Active in early to growth-stage investments, they apply a data-driven strategy to identify and nurture innovative companies poised for market disruption. This blend of expertise and regional focus has established a robust portfolio with impressive returns.